Abstract
Vasopressin (AVP) secretion and release are regulated by a number of central nervous system sites that receive peripheral signals from the osmoreceptors and baroreceptors. Aim of this paper is to review anatomical pathways and neurotransmitters involved as well as drugs affecting AVP secretion.
Keywords: Vasopressin, osmoreceptors, baroreceptors, circumventricular organs, osmolality, central nervous system, anatomical pathways, neurotransmitters, AVP secretion, hypothalamus.
Current Pharmaceutical Design
Title:Vasopressin Secretion Control: Central Neural Pathways, Neurotransmitters and Effects of Drugs
Volume: 18 Issue: 30
Author(s): Michele Iovino, Edoardo Guastamacchia, Vito Angelo Giagulli, Brunella Licchelli and Vincenzo Triggiani
Affiliation:
Keywords: Vasopressin, osmoreceptors, baroreceptors, circumventricular organs, osmolality, central nervous system, anatomical pathways, neurotransmitters, AVP secretion, hypothalamus.
Abstract: Vasopressin (AVP) secretion and release are regulated by a number of central nervous system sites that receive peripheral signals from the osmoreceptors and baroreceptors. Aim of this paper is to review anatomical pathways and neurotransmitters involved as well as drugs affecting AVP secretion.
Export Options
About this article
Cite this article as:
Iovino Michele, Guastamacchia Edoardo, Angelo Giagulli Vito, Licchelli Brunella and Triggiani Vincenzo, Vasopressin Secretion Control: Central Neural Pathways, Neurotransmitters and Effects of Drugs, Current Pharmaceutical Design 2012; 18 (30) . https://dx.doi.org/10.2174/138161212802651607
DOI https://dx.doi.org/10.2174/138161212802651607 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Risk Factors and Potential Preventive Measures for Vascular Disease Progression in Hemodialysis Patients
Vascular Disease Prevention (Discontinued) Perioperative Management of Intracranial Aneurysm and Subarachnoid Hemorrhage
Current Pharmaceutical Design Clinical Vignettes: Integrated Care of Cancer Patients by Oncologists and Cardiologists
Current Cardiology Reviews Prolonged Exposure to Ketamine Increases Brain Derived Neurotrophic Factor Levels in Developing Rat Brains
Current Drug Safety Oleanolic Acid and Related Triterpenoids from Olives on Vascular Function: Molecular Mechanisms and Therapeutic Perspectives
Current Medicinal Chemistry Facing Up the ROS Labyrinth - Where To Go?
Current Vascular Pharmacology Therapeutical Relevance of MAP-Kinase Inhibitors in Renal Diseases: Current Knowledge and Future Clinical Perspectives
Current Medicinal Chemistry Clinical Analysis Methods of Voice Disorders
Current Bioinformatics Members of CRF Family and their Receptors: From Past to Future
Current Medicinal Chemistry Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review
Current Molecular Medicine Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets Vascular and Cellular Calcium in Normal and Hypertensive Pregnancy
Current Clinical Pharmacology Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Treatment of Diabetic Foot Ulcer: An Overview Strategies for Clinical Approach
Current Diabetes Reviews Vasopressin in Liver Disease – Should We Turn On or Off?
Current Clinical Pharmacology The Cardiorenal Syndrome: Pathophysiologic Crosstalk, Outcomes, and Treatment Targets
Cardiovascular & Hematological Disorders-Drug Targets The Pursuit of Differentiated Ligands for the Glucocorticoid Receptor
Current Topics in Medicinal Chemistry Purine Derivatives as Ligands for A3 Adenosine Receptors
Current Topics in Medicinal Chemistry Immunotherapy of Kidney Cancer
Current Clinical Pharmacology Phenothiazines as Anti-Multi-Drug Resistant Tubercular Agents
Infectious Disorders - Drug Targets